Advanced Biomedical Research
Is chronic kidney disease, a predictor of in-hospital mortality in Coronavirus Disease 2019 (COVID-19) patients?
Authors
- Firouzeh Moeinzadeh 1
- Vahideh Raeisi 2
- Media Babahajiani 3
- Mojgan Mortazavi 1
- Samaneh Pourajam 2
- Shiva Seirafian 1
- Mohammad Shirzadi 2
- Shahram Taheri 1
- Mehrdad Salahi 4
- Marjan Mansourian 5
- Arash Toghyani 6
- Zahra Zamani 1
1 Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Internal Medicine, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran
3 Student Research Committee, Vice Chancellor for Research and Technology, Kurdistan University of Medical Sciences, Sanandaj, Iran
4 Department of Infectious Disease, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran
5 Epidemiology and Biostatics Department, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
6 Medical School, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: Chronic kidney disease (CKD) is an important comorbidity in Coronavirus Disease 2019 (COVID-19) patients considering its high prevalence. We aimed to figure out the relationship between CKD and COVID-19 mortality in this study.
Materials and Methods: In total, 116 CKD patients (estimated glomerular filtration rate [eGFR] lower than 60 mL/min/1.73 m2) and 147 control subjects confirmed with COVID-19 were studied. Data regarding demographics, sign and symptoms, laboratory findings, and chest computed tomography were collected. Association between CKD and in-hospital mortality were analyzed using logistic regression models adjusted for confounders.
Results: Mortality rate was significantly higher in CKD than non-CKD (30.17 vs 4.76, P < 0.001) COVID-19 patients. Multivariate logistic regression showed that CKD was significantly correlated with in-hospital mortality in the total sample (Odds ratio (OR) = 8.64, confidence interval (CI): 3.67–20.35) and gender subgroups (females: OR = 4.77, CI: 1.38–16.40, males: OR = 13.43, CI: 3.85–46.87) (P < 0.05) of COVID-19 patients in the crude model. Whereas, the correlation did not remain significant in the fully adjusted model in the total sample (OR = 1.70, CI: 0.35–8.19) and gender subgroups (females: OR = 1.07 CI: 0.06–19.82, males: OR = 0.87, CI: 0.07–10.33) (P > 0.05) of COVID-19 patients.
Conclusion: This study suggested an independent association between CKD and in-hospital mortality in COVID-19 patients. Therefore, more intensive surveillance of COVID-19 patients with CKD is to be warranted.
Keywords
| 1. |
World Health Organization. Novel coronavirus—china. 2020. Available from: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en.  |
| 2. |
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. JAutoimmun 2020;109:102433. |
| 3. |
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. |
| 4. |
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020;323:1061-9. |
| 5. |
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420-2. |
| 6. |
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: Aretrospective cohort study. Lancet 2020;395:1054-62. |
| 7. |
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: Asystematic review and meta-analysis. IntJInfect Dis 2020;94:91-5. |
| 8. |
Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. IntUrolNephrol 2020;52:1193-4. |
| 9. |
Rapp JL, Lieberman-Cribbin W, Tuminello S, Taioli E. Male sex, severe obesity, older age, and chronic kidney disease are associated with COVID-19 severity and mortality in New York City. Chest 2021;159:112–5. |
| 10. |
Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, et al. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. J Med Virol 2020;92:1875-83. |
| 11. |
Yamada T, Mikami T, Chopra N, Miyashita H, Chernyavsky S, Miyashita S. Patients with chronic kidney disease have a poorer prognosis of coronavirus disease 2019 (COVID-19): An experience in New York City. Int Urol Nephrol 2020;52:1405–6. |
| 12. |
Ozturk S, Turgutalp K, Arici M, Odabas AR, Altiparmak MR, Aydin Z, et al. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: Anationwide analysis from Turkey. Nephrol Dial Transplant 2020;35:2083-95. |
| 13. |
Wang X, Fang J, Zhu Y, Chen L, Ding F, Zhou R, et al. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital. Clin Microbiol Infect 2020;26:1063-8. |
| 14. |
Saran R, Robinson B, Abbott KC, Agodoa LY, Albertus P, Ayanian J, et al. US renal data system 2016 annual data report: Epidemiology of kidney disease in the United States. AmJKidney Dis 2017;69:A7-8. |
| 15. |
Ishigami J, Grams ME, Chang AR, Carrero JJ, Coresh J, Matsushita K. CKD and risk for hospitalization with infection: The Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis 2017;69:752-61. |
| 16. |
Dalrymple LS, Katz R, Kestenbaum B, De Boer IH, Fried L, Sarnak MJ, et al. The risk of infection-related hospitalization with decreased kidney function. Am J Kidney Dis 2012;59:356-63. |
| 17. |
Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. ClinExp Nephrol 2019;23:437-47. |
| 18. |
Imam Z, Odish F, Gill I, O'Connor D, Armstrong J, Vanood A, et al. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. J Intern Med 2020;288:469-76. |
| 19. |
Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism 2020;108:154262. |
| 20. |
Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect 2020;80:e14-8. |
| 21. |
Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender differences in patients with COVID-19: Focus on severity and mortality. FrontPublic Health 2020;8:152. |
| 22. |
Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Sex-Bias in COVID-19: Ameta-analysis and review of sex differences in disease and immunity. Available at SSRN 3572881. 2020 Apr 6. |
| 23. |
Jain V, Yuan JM. Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection. medRxiv 2020. |
| 24. |
Fang X, Li S, Yu H, Wang P, Zhang Y, Chen Z, et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: Asystematic review and meta-analysis. Aging (Albany NY) 2020;12:12493-503.
|
)